TSH Resources Berhad - Deemed Within Expectations

Date: 21/08/2020

Source  :  KENANGA
Stock  :  TSH       Price Target  :  1.10      |      Price Call  :  HOLD
        Last Price  :  1.11      |      Upside/Downside  :  -0.01 (0.90%)

1FY20 CNP of RM34.9m (+53% YoY) is deemed within both our (55%) and consensus’ (56%) expectation. 1HFY20 FFB output is also within at 46%. Sequential earnings improvement is anticipated in 3QFY20 on higher CPO prices (QTD 3QFY20: +17%). No changes to earnings estimate. Still a MARKET PERFORM with an unchangedTP of RM1.10 on FY21E PBV of 0.9x, reflecting mean. Reward-to-risk favours the latter at this juncture as CPO price, the leading indicator, is likely to come under pressure on rising inventory.

Deemed within expectations. 2QFY20 Core Net Profit (CNP) came in at RM10.6m (+19% YoY; -57% QoQ), which brought 1HFY20 CNP to RM34.9m (+53% YoY) - deemed within both our (55%) and consensus’ (56%) estimates. 1HFY20 FFB output of 427k MT (+5% YoY) is within our expectation, accounting for 46% (5-year average: 45%) of full-year estimate. The absence of dividend is as expected.

Results’ highlight. YoY, 1HFY20 CNP leapt (+53%) on the back of: (i) higher average CPO price (+23%), and (ii) higher FFB output (+5%). As a result, plantation EBIT margin expanded (+9.2ppt) to 18.6%, leading to a 137% increase in plantation segment profit. QoQ, 2QFY20 CNP fell (-57%) as lower average CPO price (-19%) overshadowed higher FFB output (+5%). Plantation EBIT margin contracted (-14.5ppt) to 10.7%, while segmental plantation profit fell (65%).

Earnings to improve in 3QFY20. Premised on higherCPO prices (QTD 3QFY20: +17% QoQ), we expect sequential improvement in 3QFY20 earnings. However, 4QFY20 earnings could suffer as we expect rising inventory as a result of peak production period and normalization of demand (as inventory replenishment efforts from countries like India and China have been completed) to exert downward pressure on CPO price.

No changes to earnings estimate as results were in line.
Maintain MARKET PERFORM with an unchanged Target Price of RM1.10 based on an unchanged FY21E PBV of 0.9x, reflecting mean. Given our view that CPO price is likely to come under pressure in anticipation of rising inventory in the coming months, we believe reward-to-risk favours the latter at this juncture and our tactical MARKET PERFORM rating is appropriate. Having said that, we view floor valuation to be at -1.0SD (0.74x PBV), translating to a price of RM0.900. At 0.74x PBV or lower, TSH is a steal.

Risks to our call include sharp increase/decline in CPO prices and a precipitous rise/fall in labour/fertiliser/transportation costs

Source: Kenanga Research - 21 Aug 2020

Share this
Labels: TSH

Related Stocks

Chart Stock Name Last Change Volume 
TSH 1.11 +0.01 (0.91%) 5,642,500 

  Be the first to like this.

I3 Messenger
Individual or Group chat with anyone on I3investor
MQ Trader
Stock Screener using Technical and Fundamental criteria
MQ Affiliate
Join the MQ Affiliate Program today to earn rewards

485  681  560  693 

Top 10 Active Counters
 YONGTAI 0.36+0.065 
 MTRONIC 0.135+0.015 
 HWGB 0.88+0.035 
 SAPNRG 0.13+0.01 
 AT 0.195+0.01 
 MTRONIC-WA 0.09+0.015 
 PHB 0.030.00 
 INIX 0.325+0.06 
 KNM 0.23+0.02 
 EAH 0.03-0.005 


1. The Equity Market Index Benchmark in Malaysia CMS
2. Trading Scenarios of Derivatives Bursa Derivatives Education Series
3. Derivatives 101 Bursa Derivatives Education Series
4. Why Trade FKLI? Bursa Derivatives Education Series
5. MQ Trader - Introduction to MQ Trader Affiliate Program MQ Trader Announcement!